Overview

Persistent Readiness Through Early Prediction Immunization Study

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study will enroll volunteers in an open-format (outside hospital) setting, to complete novel data collection/analysis of biomarkers, facial images, and audio-recording to establish an optimal set of parameters to predict emergent cases of infection via an early warning score, along with actionable personalized information.
Phase:
Early Phase 1
Details
Lead Sponsor:
Texas A&M University
Collaborators:
Philips Healthcare
US Department of Defense - Defense Threat Reduction Agency
Treatments:
Heptavalent Pneumococcal Conjugate Vaccine